Podcast


Presenter: Adrienne J Lindblad BSP ACPR PharmD G. Michael Allan MD CCFP James McCormack BSc(Pharm) PharmD

Podcast: BS Medicine Episode #506: Removing the pain from dealing with chronic pain
0:00

In episode 506, James and Mike invite Adrienne Lindblad to discuss our latest clinical practice guideline on the management of chronic low back, osteoarthritic, and neuropathic pain in primary care. In this episode we describe the development process and then highlight the best available evidence, including both benefits and harms, for chronic osteoarthritis treatments. We…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here



CFPCLearn Logo

Listening to the Podcast can earn you MainPro+ Credits

Join Now

Already a CFPCLearn Member? Log in



Latest Podcasts

BS Medicine Episode #618: From Nerve Pain to Knee Pain: Gabapentinoids for osteoarthritis

In episode 618, Mike K and James chat with Émélie Braschi who helps us go over, yet again, the evidence for the use of gabapentinoids. This time it is for…
Listen 0.5 credits available

BS Medicine Episode #617: A Whiff of Prevention: Treating Male Partners to Reduce Bacterial Vaginosis Recurrence

In episode 617, Tina and James bring in Caitlin Finley to review the latest trial that attempts to answer the question of does treating male sexual partners of females undergoing…
Listen 0.5 credits available

BS Medicine Episode #616: Taking the “ouch” out of IUD insertion: Can topical lidocaine help?

In episode 616, Tina and James discuss the issue around the evidence for using topical anesthetics to reduce the pain associated with IUD insertion. To help with this discussion, we…
Listen 0.5 credits available

Presenter(s):

Adrienne J Lindblad BSP ACPR PharmD G. Michael Allan MD CCFP James McCormack BSc(Pharm) PharmD

This content is certified for MainPro+ Credits, log in to access


Presenter(s):

  • Adrienne J Lindblad BSP ACPR PharmD
  • G. Michael Allan MD CCFP
  • James McCormack BSc(Pharm) PharmD

Spearkers do not have any conflicts of interest to declare.